Assessment of some blood parameters as potential markers of hepatic copper accumulation in cattle.
The increasing frequency of copper (Cu) toxicosis episodes in cattle in recent years, mainly associated with excess Cu supplementation, underscores the need to identify animals in the clinically silent phase of hepatic Cu accumulation. The aim of the study reported here was to evaluate the suitability of various blood parameters as potential early markers of hepatic Cu accumulation in cattle. Paired liver and blood samples from 70 calves aged 6 to 10 months were obtained at slaughter in a region in northwestern Spain where animals usually have hepatic Cu concentration higher than safe values. Neither serum Cu concentration nor ceruloplasmin (CP) concentration, the 2 parameters most commonly used for diagnosis of Cu deficiency, were significantly associated with hepatic Cu concentration. However, whole-blood Cu concentration had a slight but significant correlation with hepatic Cu concentration (r = 0.269, P = 0.026). The use of calculated blood parameters, such as the serum or whole-blood non-CP Cu fraction, or the CP-to-serum Cu ratio, increased the correlation with the hepatic Cu concentration (r = 0.393, P = 0.001, in the case of whole-blood, non-CP Cu concentration), but the strength of the association remained insufficient for accurate prediction of hepatic Cu values. Likewise, hepatic enzyme (aspartate transaminase and gamma-glutamyltransferase) activities were significantly or nearly correlated significantly with hepatic Cu concentration, but the strength of the association remained too low for accurate prediction. It is concluded that direct analysis of Cu concentration in liver biopsy specimens--preferably postmortem liver samples obtained at slaughter--is the best technique currently available for detecting chronic subclinical Cu accumulation in cattle at risk for supraoptimal Cu exposure.
Universidade de Santiago de Compostela, Departamento de Patoloxía Animal, Facultade de Veterinaria, Lugo, Spain.
Marta
M
López-Alonso
Antonio
A
Crespo
Marta
M
Miranda
Cristina
C
Castillo
Joaquín
J
Hernández
José Luis
JL
Benedito
D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers / Q000097:blood; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood / Q000378:metabolism*; D002570:Ceruloplasmin / Q000032:analysis; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000378:metabolism / Q000662:veterinary*; D003300:Copper / Q000097:blood / Q000493:pharmacokinetics* / Q000633:toxicity*; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D015995:Prevalence; D005723:gamma-Glutamyltransferase / Q000097:blood
D015415:Biomarkers; D003300:Copper; D002570:Ceruloplasmin; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase